301277.SZ Stock Analysis
30
Uncovered
Henan Newland Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Market cap $B
0.756
Dividend yield
1.74 %
Shares outstanding
133.36 B
Henan Newland Pharmaceutical Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company's main business is the research and development, production and sales of pharmaceutical intermediates. The Company's main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid, including D-acid, methyl ester and hydroxydeng salt. The Company also produces pharmaceutical resolution agents. The Company mainly operates its businesses in the domestic and overseas markets.